All items in the Healthy Skepticism Library
All the 20111 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 199 of 202 pages ‹ First < 197 198 199 200 201 > Last ›
HSL2821
Schreier HA, Berger L.
Letter: On medical imperialism.
Lancet 1974 Jun 8;1:(7867):1161
HSL8862
Walters PG.
FDA's program to improve consumers' and health professionals' ability to select medically effective drugs
Hosp Formul Manage 1974 Jun;9:17-20, 50
HSL2826
Gould D.
Can we handle modern drugs?
New Scientist 1974 May 23;62:(899):460-1
HSL2827
Greenberg D.
Cleaning up the drug trade
New Scientist 1974 May 23;62:491
HSL8869
Inquisitive Federal Trade Commission (FTC) starts poking into pharmacy field
American Druggist 1974 May 1;169:74-75
HSL8854
Schamberg IL.
The quality and cost of prescription drugs.
J Am Pharm Assoc 1974 May;14:(5):241-3
HSL8861
Pendergast WR.
FDA regulations-a ten-year assessment
Medical Marketing and Media 1974 May;9:20, 22, 26-27
HSL2813
Hemminki E.
The effect of a doctor's personal characteristics and working circumstances on the prescribing of psychotropic drugs.
Med Care 1974 Apr;12:(4):351-7
HSL8870
Decristoforo R, Fortner CL.
Review of potential drug interactions between OTC (over-the-counter) and prescription drugs
Hosp Formul Manage 1974 Apr;10:20-31, 41
HSL8866
Davis S.
Update on computerized media evaluation
Medical Marketing and Media 1974 Mar;9:13-15
HSL8874
Display the prescription price poster, but not too conspicuously
Am Drug Merch 1974 Feb 1;169:32-36, 46
HSL8859
Miller R.
Prescribing habits of physicians. Parts 7-8. Sources of information on drugs and their influence on prescribing and a theoretical model for the adoption of drug innovations
Drug Intell Clin Pharm 1974 Feb;8:81-91
HSL8863
Hoare RG.
Pharmaceutical company
Postgrad Med J 1974 Feb;50:85-87
HSL2806
Denies ads mislead, manipulate
Drug Merchandising 1974;55:(4):51
HSL2807
Findings and conclusions of the NCCC [National Council of Churches of Christ] project on drug advertising
Journal of Drug Issues 1974;4:310-312
HSL2808
Bowes R.
The industry as pusher
Journal of Drug Issues 1974;4:238-242
HSL2809
Cooperstock R.
Some factors involved in the increased prescribing of psychotropic drugs
Alcoholism and Drug Addiction Research Foundation of Ontario 1974;
HSL2811
Greenfield P, Wolff F.
The pressures of drug advertising on physicians and patients
Journal of Drug Issues 1974;4:254-259
HSL2812
Hay DR.
Postal pollution
New Zealand Medical Journal 1974;80:464
HSL2814
Hess SW.
Communicating with physicians
Journal of Advertising Research 1974;14:(1):13-18
HSL2815
Kallir J.
An advertiser’s view of drug advertising
Journal of Drug Issues 1974;4:283-286
HSL2816
Knight JL, Baumgartner RP.
Quality control information—its availability from pharmaceutical manufacturers
Hospital Formulary Management 1974;9:(9):35, 37, 40-42, 50
HSL2818
Miller RR.
Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts VII-Viii
Drug Intelligence and Clinical Pharmacy 1974;8:81-91
HSL2820
Nelson G.
New laws are needed to regulate the drug industry
Journal of Drug Issues 1974;4:243-248
HSL2822
Seidenberg R.
Images of health, illness and women in drug advertising
Journal of Drug Issues 1974;4:264-267
HSL2823
Turner J.
Weaknesses in the system of promoting and marketing drugs
Journal of Drug Issues 1974;4:260-263
HSL2824
Wolfe SM.
Scientific evaluations dispute advertising claims
Journal of Drug Issues 1974;4:249-253
HSL2828
Barclay WR.
The American Medical Association's policy on drug advertising
Journal of Drug Issues 1974;4:287-290
HSL2829
Berger AA.
Drug advertising and the "pain, pill, pleasure" model
Journal of Drug Issues 1974;4:208-212
HSL2830
Braren W.
Deception in advertising and the failure of self-regulation
Journal of Drug Issues 1974;4:213-216
HSL2831
Donegan TJ.
The role of the Federal Trade Commission in regulating over-the-counter drug advertising
Journal of Drug Issues 1974;4:232-237
HSL2832
Johnson N.
Junkie television
Journal of Drug Issues 1974;4:227-231
HSL2833
Kanter DL.
Research on the effects of over-the-counter drug advertising
Journal of Drug Issues 1974;4:223-226
HSL2834
Panel , Donegan , Warnke , Bowes , Turner , Stetler , Simmons .
Special discussion of two major questions
Journal of Drug Issues 1974;4:297-309
HSL2835
Penna RD.
American Pharmaceutical Association
Journal of Drug Issues 1974;4:268-273
HSL2836
Simmons H.
The role of the Food and Drug Administration in regulating drug advertising
Journal of Drug Issues 1974;4:291-296
HSL2837
Warnke P, O'Keefe D, Kiev A.
The Proprietary Association replies to the critics
Journal of Drug Issues 1974;4:217-222
HSL8864
Dyer AE.
PARCOST: the Ontario experience in selecting quality drugs
Drugs Health Care 1974;1:(1):16-26
HSL8865
Bowes R.
Industry as pusher
Journal of Drug Issues 1974;4:(3):238-242
HSL8868
Stetler CJ, Coe F.
Pharmaceutical Manufacturers Association responds to the critics
Journal of Drug Issues 1974;4:(3):274-282
HSL8878
Turnbull JC.
Can Pharm Ass rejects prescription advertising
Canadian Pharmaceutical Journal 1973 Dec;106:368-372
HSL8872
Wertheimer AI, Knoben JE.
The mail-order prescription drug industry.
Health Serv Rep 1973 Nov;88:(9):852-6
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=4586284
HSL8879
Segal HJ.
Ontario's PARCOST (prescriptions at reasonable cost) program
Canadian Pharmaceutical Journal 1973 Nov;106:346-351
HSL8876
Huskisson EC.
Trade names or proper names? A problem for the prescriber
British Medical Journal 1973 Oct 27;4:225-228
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=4758398
HSL2804
Dunne M, Newman M, Herxheimer A, Ridley H.
Indications and warnings about chloramphenicol.
Lancet 1973 Oct 6;2:(7832):781-3
HSL2342
Waxburg JD.
What motivates a physician to try a new product?
Med Mark Media 1973 Jul 8;13-15
HSL8857
Brogle RC.
Effect of the OTC review on the future of proprietary drug research
Drug Information Journal 1973 Jul-Dec;7:71-74
HSL2803
Williams JD, Geddes AM.
Advertising of antibiotics.
Br Med J 1973 Jun 9;2:(5866):613
HSL1880
Goulston K.
Problems of postgraduate medical education.
Aust N Z J Med 1973 Jun;3:(3):230-8
HSL2798
Parish PA.
What influences have led to increased prescribing of psychotropic drugs?
J R Coll Gen Pract 1973 Jun;23:Suppl:
HSL2799
Simpson FO.
Omissions in advertising.
N Z Med J 1973 Jun;77:(493):412
HSL2802
Worthen DB.
Prescribing influences: an overview.
Br J Med Educ 1973 Jun;7:(2):109-17
HSL8873
Thompson AWS.
Prescribing of hypnotics and tranquilizers in New Zealand
Pharm J N Z 1973 Apr;35:15-18
HSL8848
Sonnedecker G.
American pharmacy--a retrospective future.
J Am Pharm Assoc 1973 Mar;13:(3):128-30
HSL2794
Hemminki E.
The quality of drug advertisements in two Finnish medical journals. A comparison between psychotropic and other drug advertisements
Soc Sci Med. 1973 Jan 01;7:(1):51-9
HSL2795
Kunnes R.
Drugs and public policy: Poly-drug abuse: drug companies and doctors
American Journal of Orthopsychiatry 1973;43:530-2
HSL2796
Miller RR.
Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts I-III
Drug Intelligence and Clinical Pharmacy 1973;7:492-500
HSL2797
Miller RR.
Prescribing habits of physicians: a review of studies on prescribing of drugs. Parts IV-VI
Drug Intelligence and Clinical Pharmacy 1973;7:557-564
HSL2800
Smart RG.
Silver bullets and overkill: ethical advertisements for psychoactive drugs
1973;14
HSL2801
Wallace JD.
An APMR? Now what would that be?
Canadian Medical Association Journal 1973;108:1302
HSL2805
Stetler CJ.
Patterns of prescription drug use: The role of promotion
Journal of Drug Education 1973;3:(4):389-402
HSL8877
Schicke RK.
The pharmaceutical market and prescription drugs in the Federal Republic of Germany: cross-national comparisons.
Int J Health Serv 1973 Spr;3:(2):223-36
HSL8883
Generic ratio continues to climb; erythromycin moves up into 8th place
American Druggist 1972 Nov 13;166:32-33
HSL8860
Bicket WJ.
Autotherapy - 'The Future is Now'
J Am Pharm Assoc 1972 Nov;12:(11):560-2
HSL8887
Daylight on prescription prices
Money 1972 Oct;1:31-34
HSL8884
Keeping the pharmaceutical industry healthy
Pharmaceutical Journal 1972 Sep 23;209:299-300
HSL8880
Rucker TD.
Economic problems in drug distribution.
Inquiry 1972 Sep;9:(3):43-50
HSL8852
Klein RJ.
The consumer's right to know.
J Am Pharm Assoc 1972 Jul;12:(7):360-1
HSL8853
Angevine E.
The concerned consumer.
J Am Pharm Assoc 1972 Jul;12:(7):356-7
HSL2789
Ingelfinger FJ.
Advertising: informative but not educational.
N Engl J Med 1972 Jun 15;286:(24):1318-9
HSL8885
Stetler CJ.
Pharmaceutical field: a house divided?
Pharmacy Times 1972 May;38:32-38
HSL2141
Linn LS, Davis MS.
Physicians' orientation toward the legitimacy of drug use and their preferred source of new drug information.
Soc Sci Med 1972 Apr;6:(2):199-203
HSL2531
Kimmey JR.
Drug efficacy and a journal's responsibility.
Am J Public Health 1972 Apr;62:(4):461-2
HSL8881
Pharmacist, the industry and the health service (Great Britain)
African Journal of Pharmacy and Pharmaceutical Sciences 1972 Mar;2:168-188
HSL2140
Becker MH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM.
Differential education concerning therapeutics and resultant physician prescribing patterns.
J Med Educ 1972 Feb;47:(2):118-27
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=5011761&query_hl=5
HSL8888
Chadduck HW.
In brief summary: prescription drug advertising, 1962-71
FDA Pap 1972 Feb;6:13-25
HSL8891
Pharmacist, the industry and the Health Service
Pharmaceutical Journal 1972 Jan 15;208:42-47
HSL8894
Damages sought for neurologic side effects of drug
Citation 1972 Jan 1;24:88-89
HSL2790
Torrance GM.
The influence of the drug industry in Canada’s health system
1972 Jan;48
HSL2793
Stolley PD, Becker MH, Lasagna L, McEvilla JD, Sloane LM.
The relationship between physician characteristics and prescribing appropriateness.
Med Care 1972 Jan-Feb;10:(1):17-28
HSL2330
Montgomery DB, Silk .
Estimating dynamic effects of market communications expenditures.
Management Sci 1972;18:B485-B501
HSL13301
Newell A, Simon HA.
Human Problem Solving
Englewood Cliffs, NJ: Prentice-Hall 1972
http://www.amazon.com/gp/product/0134454030/sr=1-1/qid=1206497977/ref=olp_product_details?ie=UTF8&me=&qid=1206497977&sr=1-1&seller=
HSL8893
Nielsen AC.
Why certain independent pharmacists are very successful
Pharmacy Times 1971 Dec;37:52-57
HSL2310
Becker MH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM.
Characteristics and attitudes of physicians associated with the prescribing of chloramphenicol.
HSMHA Health Rep 1971 Nov;86:(11):993-1003
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed
HSL8889
Vogt DD, Billups NF.
The merger movement in the American pharmaceutical complex.
J Am Pharm Assoc 1971 Nov;11:(11):588-91
HSL8898
Lees KA, Roxburgh A.
Pharmaceutical industry and the hospital pharmacist. Part 1. An industrialist's view. Part 2. A hospital pharmacist's view
Pharmaceutical Journal 1971 Oct 18;207:270-278
HSL8896
Klein T.
Rx drug promotion: big changes are coming
Drug Cosmet Ind 1971 Oct;109:40-44, 143-146
HSL8899
1970 Financial data for 264 drug field firms is shown
Drug Trade News 1971 Sep 20;46:15-21
HSL8892
Gaitonde PR.
Price control on drugs
Pharm-News-Ludhiana 1971 Sep;20:26-32
HSL8895
Statement of the American Pharmaceutical Association to the monopoly subcommittee of the Senate Small Business Committee of the United States Senate
J Am Pharm Assoc 1971 Sep;11:468-473
HSL8890
Feldmann EG.
Brand name system-an intrusion upon the profession
J Am Pharm Assoc 1971 Jul;11:376-379, 390
HSL2788
Waite A.
The future of pharmaceutical drug promotion
Medical Marketing & Media 1971 Jun9, 12, 14, 16, 18
HSL2766
Seidenberg R.
Advertising and abuse of drugs.
N Engl J Med 1971 Apr 8;284:(14):789-90
HSL1881
Barnes CJ, Holcenberg JS.
Student reactions to pharmaceutical promotion practices.
Northwest Med 1971 Apr;70:(4):262-6
HSL2530
Greenblatt DJ, Shader RI.
Meprobamate: a study of irrational drug use.
Am J Psychiatry 1971 Apr;127:(10):1297-303
HSL8901
Douville AW.
Drug industry
New Physician 1971 Mar;20:139-145
HSL8902
Steele HB.
Prices and profits in the drug industry: An economist's view
New Physician 1971 Mar;20:146-159
HSL8903
Stetler CJ.
Manufacturers face health care problems
New Physician 1971 Mar;20:161-163
HSL2783
Seidenberg R.
Drug advertising and perception of mental illness.
Ment Hyg 1971 Jan;55:(1):21-31
HSL2786
Usdin G.
The coin needn't smell: A response to the Seidenberg thesis
Mental Hygiene 1971 Jan;55:32-35
Page 199 of 202 pages ‹ First < 197 198 199 200 201 > Last ›
